Unjha Formulations Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

Quality Assessment: Weak Fundamentals Persist

Despite the upgrade in rating, Unjha Formulations continues to exhibit weak fundamental quality. The company reported flat financial performance in the fourth quarter of FY25-26, with operating losses underscoring its fragile operational health. Specifically, the quarterly PBDIT stood at a negative ₹0.45 crore, while PBT excluding other income was also negative at ₹0.49 crore. Earnings per share (EPS) for the quarter plunged to a low of -₹1.65, signalling persistent profitability challenges.

Moreover, the company’s ability to service debt remains poor, with an average EBIT to interest coverage ratio of just 0.49, indicating significant financial strain. This weak long-term fundamental strength is a critical factor weighing against the stock, despite any short-term technical improvements.

Valuation: Attractive but Risky

On the valuation front, Unjha Formulations presents a mixed picture. The stock trades at a price-to-book (P/B) ratio of 2.3, which is considered very attractive relative to its sector peers. Additionally, the company boasts a return on equity (ROE) of 18.5%, suggesting efficient use of shareholder capital in generating profits. The PEG ratio of 0.2 further indicates that the stock is undervalued relative to its earnings growth potential, as profits have risen by 31% over the past year despite a negative stock return of -14.89% during the same period.

However, the stock’s micro-cap status and underperformance relative to benchmarks such as the BSE500 and Sensex over the last one year (-14.89% vs. Sensex’s -6.40%) and year-to-date (-20.00% vs. Sensex’s -10.25%) introduce considerable risk. Investors should weigh these valuation advantages against the company’s operational and market challenges.

Financial Trend: Flat to Negative Performance

Financial trends for Unjha Formulations remain subdued. The company’s quarterly results for March 2026 showed no improvement, with operating losses persisting and key profitability metrics at their lowest levels. The stock’s returns over various periods further highlight its struggles: a negative 14.89% over the past year, underperforming the Sensex’s 6.40% decline and the BSE500 index. Even over the year-to-date period, the stock has declined by 20.00%, nearly double the Sensex’s fall of 10.25%.

Longer-term returns offer a more positive perspective, with the stock generating 36.52% over three years and an impressive 103.25% over five years, outperforming the Sensex’s 51.05% over the same period. However, the recent downward trend and flat quarterly results suggest caution for investors seeking near-term gains.

Technical Analysis: Mildly Bearish to Mildly Bullish Shift

The primary driver behind the upgrade from Strong Sell to Sell is the improvement in technical indicators. The technical grade has shifted from bearish to mildly bearish, signalling a tentative positive momentum. Weekly MACD readings have turned mildly bullish, while monthly MACD remains mildly bearish, reflecting a mixed but improving trend.

Other technical indicators present a nuanced picture: the weekly KST (Know Sure Thing) is mildly bullish, though monthly KST remains bearish. Bollinger Bands show a mildly bearish stance on the weekly chart and bearish on the monthly chart. Moving averages on the daily timeframe remain bearish, indicating that short-term momentum is still weak.

Relative Strength Index (RSI) readings on both weekly and monthly charts show no clear signal, while Dow Theory trends remain neutral with no definitive trend on weekly or monthly timeframes. The stock’s On-Balance Volume (OBV) data is inconclusive, providing no strong directional bias.

Price action has been modestly positive on the day of the upgrade, with the stock closing at ₹20.00, up 3.47% from the previous close of ₹19.33. The 52-week range remains wide, with a high of ₹30.40 and a low of ₹18.60, indicating significant volatility.

Shareholding and Market Capitalisation

Unjha Formulations is classified as a micro-cap stock, which inherently carries higher volatility and risk. The majority of shareholders are non-institutional, which may contribute to less stable trading patterns and liquidity concerns. This shareholder composition often results in greater price swings and less analyst coverage, factors that investors should consider when evaluating the stock’s prospects.

Comparative Performance and Outlook

While Unjha Formulations has demonstrated strong long-term returns over five and ten years—103.25% and 120.99% respectively—these gains lag behind the Sensex’s 195.54% return over the past decade. The stock’s recent underperformance and flat financial results suggest that the company is facing headwinds that may limit near-term upside.

Investors should note that the upgrade to a Sell rating from Strong Sell is primarily a reflection of technical improvements rather than a fundamental turnaround. The company’s weak debt servicing ability, operating losses, and underwhelming quarterly results remain significant concerns. However, the attractive valuation metrics and improving technical signals may offer some support for a cautious, risk-tolerant investor.

Conclusion: A Cautious Upgrade Reflecting Technical Recovery

Unjha Formulations Ltd’s rating upgrade to Sell from Strong Sell on 25 May 2026 is a nuanced development. It reflects a mild technical recovery amid persistent fundamental weaknesses. The company’s flat financial performance, operating losses, and poor debt coverage ratios continue to weigh heavily on its investment appeal. Conversely, attractive valuation metrics such as a low PEG ratio and a solid ROE provide some counterbalance.

Technical indicators have improved from bearish to mildly bearish, with weekly MACD and KST turning mildly bullish, suggesting a tentative positive momentum. However, daily moving averages and monthly technicals remain bearish, indicating that the stock is not yet out of the woods.

For investors, this upgrade signals a potential stabilisation in price action but does not yet justify a bullish stance. The stock remains a micro-cap with high volatility and a predominantly non-institutional shareholder base, factors that add to its risk profile. Careful monitoring of upcoming quarterly results and technical trends will be essential before considering a more optimistic outlook.

Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →